• Home >
  • Publications >
  • Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

1 Oct 2015European Journal of Surgical Oncology (EJSO)

DOI : 10.1016/j.ejso.2015.07.012

Authors

G. Ferron, L. Simon, F. Guyon, O. Glehen, D. Goere, D. Elias, M. Pocard, L. Gladieff, J.M. Bereder, C. Brigand, J.M. Classe, J.M. Guilloit, F. Quenet, K. Abboud, C. Arvieux, F. Bibeau, C. De Chaisemartin, D. Delroeux, S. Durand-Fontanier, N. Goasguen, L. Gouthi, B. Heyd, R. Kianmanesh, E. Leblanc, V. Loi, G. Lorimier, F. Marchal, P. Mariani, C. Mariette, P. Meeus, S. Msika, P. Ortega-Deballon, J. Paineau, D. Pezet, G. Piessen, N. Pirro, C. Pomel, J. Porcheron, G. Pourcher, P. Rat, J.M. Regimbeau, C. Sabbagh, E. Thibaudeau, J.J. Torrent, D. Tougeron, J.J. Tuech, F. Zinzindohoue, P. Lundberg, F. Herin, L. Villeneuve